Chapter 17. Aldose Reductase Inhibitors as a New Approach to the Treatment of Diabetic Complications

This publication has 74 references indexed in Scilit:

• Impaired rat sciatic nerve sodium-potassium adenosine triphosphatase in acute streptozocin diabetes and its correction by dietary myo-inositol supplementation.
  Journal of Clinical Investigation, 1983
• Sorbitol, inositol and nerve conduction in diabetes
  Life Sciences, 1983
• Aldose Reductase Inhibition Improves Nerve Conduction Velocity in Diabetic Patients
  New England Journal of Medicine, 1983
• EFFECT OF 1 YEAR OF NEAR-NORMAL BLOOD GLUCOSE LEVELS ON RETINOPATHY IN INSULIN-DEPENDENT DIABETICS
  The Lancet, 1983
• Sodium- and energy-dependent uptake of myo-inositol by rabbit peripheral nerve. Competitive inhibition by glucose and lack of an insulin effect.
  Journal of Clinical Investigation, 1982
• Selective effects of myo-inositol administration on sciatic and tibial motor nerve conduction parameters in the streptozocin-diabetic rat
  Diabetes, 1982
• Studies on antidiabetic agents. III. 5-Arylthiazolidine-2,4-diones as potent aldose reductase inhibitors.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1982
• Inhibition of oxidative enzymes by anti-allergy drugs
  Inflammation Research, 1981
• Synthesis and aldose reductase inhibitory activity of 7-sulfamoylxanthone-2-carboxylic acids
  Journal of Medicinal Chemistry, 1980
• Role of nonenzymatic glycosylation in experimental cataract formation
  Biochemical and Biophysical Research Communications, 1980